Latin American Internet Survey for Men who have Sex with Men

LAMIS (Latin America MSM Internet Survey) is an online survey on the sexual health of gay men, bisexual men and other men who have sex with men (MSM). It is the Latin American version of EMIS (European MSM Internet Survey), a similar survey that has been carried out in European countries in 2010 and 2017. The survey asks about sexual behavior, HIV / STI prevention, drug use , homophobia, psychosocial health and access to health services, among other topics.

LAMIS 2018 finished data collection in May 12th 2018. Is currently in data analysis phase. LAMIS 2018 is the first project from the Red Iberoamericana de Estudios en Hombres Gay, Otros HSH y Personas Trans 

 

What is LAMIS 2018?

In many Latin American countries, discrimination and lack of data are factors that contribute to poor or non-existent health policies to address the needs of men who have sex with men (MSM). In addition, in Latin America, some sexually transmitted infections (including HIV) occur at high rates in this population. Considering the disparities between countries regarding the existence of discriminatory laws and inclusive policies, data on various aspects of the health of that population are needed so that projects and policies that positively impact MSM are developed based on the reported needs. In this context, LAMIS 2018 is the first community study on sexual health among MSM that takes place in Latin America. LAMIS 2018 will provide a detailed picture of a wide range of aspects relating to the psycho-socio-sexual health of MSM in the region.

The study will contribute to knowledge of dynamic models of the HIV epidemic, and the emerging epidemics of other sexually transmitted infections, which is one of the main strategic objectives of the project in order to develop effective responses to these diseases. Sexual orientation is not a variable present in national censuses, and therefore, there is no information on the size and other characteristics of the MSM population in most Latin American countries. At the national level, LAMIS 2018 will generate data to understand the needs of prevention programs. At the international level, it will generate knowledge about variations in health services and policies between countries, and the corresponding impact on the spread and control of HIV and other STIs.

 

What are the objectives of LAMIS 2018?

  • To determine the sociodemographic characteristics of men who have sex with men (MSM) of diverse sexual identities in the participating countries, detailing by age, education and region

  • To determine knowledge about HIV and other STIs among MSM of diverse sexual identities in the participating countries, detailing by age, schooling and region.

  • To carry out a comparative analysis at a Latin American and European level on social characteristics, knowledge, sexual behaviors and access to health services for MSM.

  • To propose interventions at national and international level which focus on prevention of HIV and other STIs for MSM in the participating countries.

  • To prepare recommendations to states and regional organizations to update strategies for the prevention of HIV and other STIs among MSM.

 

About us

The implementation and execution of LAMIS 2018 was carried out by researchers from the Red Iberoamericana de Estudios en Hombres Gay, Otros HSH y Personas Trans  and researchers involved in the EMIS2017 study:

Dra. Maria Amélia Veras (Brazil)

Faculdade de Ciências Médicas da Santa Casa de São Paulo, Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT+

 

Dra. Valeria Stuardo Ávila (Chile)

Escuela de Salud Pública, Universidad de Chile, Santiago

 

Dr. Carlos Cáceres (Peru)

Facultad de Salud Pública, Universidad Peruana Cayetano Heredia, Lima

Coordinator of the Red in Latin America

 

​Elsy Camey (Guatemala)

Fundació Sida i Societat, Ciudad de Guatemala

Dr. Kai J. Jonas (The Netherlands)

Faculty of Psychology and Neuroscience - Maastricht University

 

Dr. Ulrich Marcus (Germany)

Robert Koch Institute, Berlin

 

 Dr. Axel J. Schmidt (United Kingdom)

Sigma Research, London School of Hygiene and Tropical Medicine, London.

 

Dr. Henrique Barros (Portugal)

EPIUnit - Instituto de Saúde Pública, Universidade do Porto

 

Dr. Jordi Casabona (Spain)

Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Barcelona

Coordinator of the Red in Europe

 

Other members of the working group:

 

Igor Prado (translation and edition of the Portuguese version of the questionnaire, Web design and design of promotion materials)

Faculdade de Ciências Médicas da Santa Casa de São Paulo, Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT+

 

Edward Reyes Diaz (data analysis)

Universidad Peruana Cayetano Heredia

 

Participating countries

By clicking on the name or logo of the institutions, you will go to the web page of that institution. Many of these organizations work on the prevention of HIV / STIs in the LGBT population, so on their website you can find information on this topic or how to access it in your country.

COLOMBIA

UNIMINUTO Seccional Bello

Asociación Ágora

COSTA RICA

CIPAC

PARAGUAY

SOMOSGAY

What resources was LAMIS 2018 carried out with?

LAMIS 2018 has been possible thanks to the contributions in the form of human, intellectual and economic resources of the member institutions of the Red Iberoamericana de Estudios en Hombres Gay, otros HSH y Personas Trans (The CEEISCAT assumed the economic and legal aspects of hosting the database and the general coordination of the project; the Institute of Public Health of the University of Porto contributed funds to host the survey in Portuguese and to the promotion of the survey; the CIISSS of the Cayetano Heredia University paid the domain for the web page of the survey; and the Faculty of Medical Sciences of Santa Casa de São Paulo paid the domain for the study website and took charge of its graphic design) and the Faculty of Psychology and Neuroscience at Maastricht University, which paid for hosting the Dutch survey in the platform. For its implementation, LAMIS 2018 had some resources used in the EMIS2017 study, which was funded by the European Commission Health Program 2014-2020, and, in particular, from Sigma Research (questionnaire design, graphic arts of banners for promotion, secondary variables syntax and EMIS2017 variables manual) and the Robert Koch Institute (negotiations with web pages/apps for free promotion of LAMIS 2018). Also, LAMIS 2018 was possible thanks to the support of the collaborating partners in each of the 18 participating countries, and to Grindr and PlanetRomeo, both of whom sent free instant messages for promotion to their user.

Contact

 

If you have questions and / or comments about the design of the survey and implementation of the LAMIS 2018 study in Latin America, you can contact to:

Ana Celly

Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT)

rightplus@ceeiscat.cat

 

If you have questions and/or comments about the implementation of the survey LAMIS 2018 in Suriname, please contact to:

 

Dr. Kai J. Jonas

Faculty of Psychology and Neuroscience - Maastricht University

kai.jonas@maastrichtuniversity.nl

If you have general questions and/or comments about the LAMIS study, please contact us:

-        in Perú, Dr. Carlos Cáceres, Universidad Peruana Cayetano Heredia

         (carlos.caceres@upch.pe);

-        in Chile, Dra. Valeria Stuardo, Escuela de Salud Pública, Universidad de Chile

          (vstuardo@med.uchile.cl);

-        in Brazil, Dra. Maria Veras, Facultad de Ciencias Médicas de la Santa Casa de Sao Paulo

          (maria.veras@gmail.com);

​-        in Guatemala, Elsy Camey, Fundación Sida y Sociedad

          (ecamey@sidaisocietat.org)

-        in Spain, Dr. Jordi Casabona, Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya           

         (jcasabona@iconcologia.net)

​-        in Portugal, Dr. Henrique Barros, Instituto de Saúde Pública da Universidade do Porto

          (hbarros@med.up.pt)

-        in Germany, Dr. Ulrich Marcus, Robert Koch Institute

          (MarcusU@rki.de)